ZA200510465B - Use of a novel eimeria gene and corresponding protein - Google Patents

Use of a novel eimeria gene and corresponding protein

Info

Publication number
ZA200510465B
ZA200510465B ZA200510465A ZA200510465A ZA200510465B ZA 200510465 B ZA200510465 B ZA 200510465B ZA 200510465 A ZA200510465 A ZA 200510465A ZA 200510465 A ZA200510465 A ZA 200510465A ZA 200510465 B ZA200510465 B ZA 200510465B
Authority
ZA
South Africa
Prior art keywords
corresponding protein
novel
eimeria gene
gene
novel eimeria
Prior art date
Application number
ZA200510465A
Other languages
English (en)
Inventor
Greif Gisela
Hosse Ralf
Kriicken Juergen
Wunderlich Frank
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ZA200510465B publication Critical patent/ZA200510465B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/012Coccidia antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455Eimeria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200510465A 2003-07-04 2005-12-23 Use of a novel eimeria gene and corresponding protein ZA200510465B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10330235A DE10330235A1 (de) 2003-07-04 2003-07-04 Neues Eimeria Gen und Protein sowie deren Verwendung

Publications (1)

Publication Number Publication Date
ZA200510465B true ZA200510465B (en) 2007-03-28

Family

ID=33521342

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200510465A ZA200510465B (en) 2003-07-04 2005-12-23 Use of a novel eimeria gene and corresponding protein

Country Status (13)

Country Link
US (1) US7691987B2 (es)
EP (2) EP2311859A1 (es)
JP (1) JP4594304B2 (es)
AR (1) AR045000A1 (es)
AU (1) AU2004255594B2 (es)
BR (1) BRPI0412323A (es)
CA (1) CA2531161A1 (es)
DE (1) DE10330235A1 (es)
MX (1) MXPA06000198A (es)
NO (1) NO20060568L (es)
NZ (1) NZ544451A (es)
WO (1) WO2005005472A1 (es)
ZA (1) ZA200510465B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2792517C (en) * 2010-03-09 2020-03-24 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations
US20110223208A1 (en) * 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
US9072668B2 (en) 2010-03-09 2015-07-07 Janssen Biotech, Inc. Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
BR112014011508B1 (pt) * 2011-11-17 2020-12-01 Dsm Ip Assets B.V. uso de uma protease estável em meio ácido
BR112014018204A8 (pt) 2012-01-24 2017-07-11 Univ Massachusetts Método de diagnóstico de distúrbio de células beta pancreáticas em um indivíduo
CN103233017B (zh) * 2013-05-06 2014-11-05 扬州大学 毒害艾美耳球虫的配子体抗原gam22基因及其应用
CN111471107B (zh) * 2020-04-27 2023-04-18 中国农业大学 抗鸡球虫多价重组蛋白卵黄抗体及其制备方法和应用
CN112592961A (zh) * 2021-01-07 2021-04-02 山东科硕生物技术有限公司 一种核酸样本保存液及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
EP0231537B1 (en) * 1985-12-03 1992-03-11 Solvay Antigenic proteins and vaccines containing them for prevention of coccidiosis
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
EP0548252A4 (en) * 1990-09-12 1995-02-15 Genex Corp Genetically engineered coccidiosis vaccine

Also Published As

Publication number Publication date
DE10330235A1 (de) 2005-01-20
EP2311859A1 (en) 2011-04-20
AU2004255594A1 (en) 2005-01-20
MXPA06000198A (es) 2006-03-21
US7691987B2 (en) 2010-04-06
JP4594304B2 (ja) 2010-12-08
AU2004255594B2 (en) 2010-12-09
BRPI0412323A (pt) 2006-08-22
EP1644407A1 (en) 2006-04-12
CA2531161A1 (en) 2005-01-20
NZ544451A (en) 2009-06-26
NO20060568L (no) 2006-03-31
AR045000A1 (es) 2005-10-12
WO2005005472A1 (en) 2005-01-20
US20070184054A1 (en) 2007-08-09
JP2008500003A (ja) 2008-01-10

Similar Documents

Publication Publication Date Title
WO2005072055A9 (en) Novel brain natriuretic peptide variants and methods of use thereof
AU2003228936A8 (en) Identification of dysregulated genes in patients with multiple sclerosis
ZA200510465B (en) Use of a novel eimeria gene and corresponding protein
EP1534840A4 (en) NEW SIRNA GENIUS LIBRARIES AND METHOD FOR THEIR MANUFACTURE AND USE
AU2003243714A8 (en) Etoposide analogs and methods of use thereof
GB0222909D0 (en) Novel process and intermediates
GB2401094B (en) Labels and methods of manufacture thereof
GB0222912D0 (en) Novel process and intermediates
EP1686979A4 (en) ACTIVATION OF HYPOXIA-INDUCIBLE GENE EXPRESSION
PL1616007T3 (pl) Inhibitory proteinowe proteazy i ich wykorzystanie
HK1094531A1 (en) P185neu-encoding dna and therapeutical uses thereof
EP1496122A4 (en) NEW MELOIDOGYNE RESISTANCE AND ITS USE
AU2003217174A8 (en) Novel variants of rankl protein
EP1644476A4 (en) NOVEL PHYTASE AND GEN
AU2003235096A1 (en) Novel protein and dna thereof
AU2003220085A8 (en) Protein a compositions and methods of use
EP1589101A4 (en) NEW PROTEIN AND ITS GENE
AU2003295311A8 (en) Caterpiller gene family
AU2003294705A8 (en) Ntsm gene
EP1725584A4 (en) NEW PHYTOCHROMIC INTERACTING PROTEIN AND USE THEREOF
EP1541677A4 (en) NEW PROTEINS AND USE THEREOF
EP1577322A4 (en) NEW PROTEINS AND THEIR USE
EP1514924A4 (en) NEW ACYLASE GENE
AU2003260487A8 (en) Novel pancortin-pablo protein interactions and methods of use thereof
AU2003262080A1 (en) Novel protein and dna thereof